(Total Views: 533)
Posted On: 02/26/2021 11:25:39 AM
Post# of 145248
FWIW I think CYDY likely has what it needs at 28 days and will set a new standard. We will find out eventually.
IMO Nader's decision to not do the 75% review & to not add the 42 days observation to the official protocol (to the best of my knowledge) also may have been strategic in a way I haven't seen mentioned. He may have realized that by NOT extending the observation period, he gives other drugs some limited ability to compare to a SOC without Leronlimab in s/c cases.
Part of me thinks this plays politics a little, but results in changing more hearts & minds at the FDA which leads to more respect with other trials.
JMO
IMO Nader's decision to not do the 75% review & to not add the 42 days observation to the official protocol (to the best of my knowledge) also may have been strategic in a way I haven't seen mentioned. He may have realized that by NOT extending the observation period, he gives other drugs some limited ability to compare to a SOC without Leronlimab in s/c cases.
Part of me thinks this plays politics a little, but results in changing more hearts & minds at the FDA which leads to more respect with other trials.
JMO
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.